Previous Article | Next Article 
Journal of Virology, February 2005, p. 1930-1933, Vol. 79, No. 3
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.3.1930-1933.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Anti-CXCR4 Monoclonal Antibodies Recognizing Overlapping Epitopes Differ Significantly in Their Ability To Inhibit Entry of Human Immunodeficiency Virus Type 1
Xavier Carnec,1
Lan Quan,2
William C. Olson,3
Uriel Hazan,2 and
Tatjana Dragic1*
Albert Einstein College of Medicine, Bronx,1
Progenics Pharmaceuticals, Inc., Tarrytown, New York,3
Institut Cochin de Génétique Moléculaire, Paris, France2
Received 26 July 2004/
Accepted 22 September 2004
CXCR4 is one of two physiologically relevant human immunodeficiency type 1 (HIV-1) entry coreceptors. Studies of CXCR4 mutants have not clearly identified the determinants of coreceptor function and specificity. We therefore used a panel of monoclonal antibodies to further elucidate CXCR4 expression, structure, and function. Our findings show the existence of conformational subpopulations of CXCR4 that are in equilibrium on the cell surface but are not cell type specific as previously reported. HIV-1 X4 isolates can interact with multiple CXCR4 conformations in order to gain entry into target cells.
* Corresponding author. Mailing address: Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-3282. Fax: (718) 430-8711. E-mail:
tdragic{at}aecom.yu.edu.
Journal of Virology, February 2005, p. 1930-1933, Vol. 79, No. 3
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.3.1930-1933.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Nimmagadda, S., Pullambhatla, M., Pomper, M. G.
(2009). Immunoimaging of CXCR4 Expression in Brain Tumor Xenografts Using SPECT/CT. JNM
50: 1124-1130
[Abstract]
[Full Text]
-
Thakkar, N., Pirrone, V., Passic, S., Zhu, W., Kholodovych, V., Welsh, W., Rando, R. F., Labib, M. E., Wigdahl, B., Krebs, F. C.
(2009). Specific Interactions between the Viral Coreceptor CXCR4 and the Biguanide-Based Compound NB325 Mediate Inhibition of Human Immunodeficiency Virus Type 1 Infection. Antimicrob. Agents Chemother.
53: 631-638
[Abstract]
[Full Text]
-
Xu, C., Sui, J., Tao, H., Zhu, Q., Marasco, W. A.
(2007). Human Anti-CXCR4 Antibodies Undergo VH Replacement, Exhibit Functional V-Region Sulfation, and Define CXCR4 Antigenic Heterogeneity. J. Immunol.
179: 2408-2418
[Abstract]
[Full Text]
-
Kalinkovich, A., Tavor, S., Avigdor, A., Kahn, J., Brill, A., Petit, I., Goichberg, P., Tesio, M., Netzer, N., Naparstek, E., Hardan, I., Nagler, A., Resnick, I., Tsimanis, A., Lapidot, T.
(2006). Functional CXCR4-Expressing Microparticles and SDF-1 Correlate with Circulating Acute Myelogenous Leukemia Cells.. Cancer Res.
66: 11013-11020
[Abstract]
[Full Text]